CSE: AIAI | OTCQB: AINMF | FRA: PF0

Driving the Business of Science: AI in Clinical Trials. A Scientist’s Perspective.

AI in Clinical Trials. A Scientist’s Perspective.

In this episode of Driving the Business of Science,Keith Parent, CEO of Court Square Group, discusses the intersection of science and business in drug development with Dr. Joseph Geraci, Founder, Chief Scientific and Technical Officer of NetraMark. Dr. Geraci, with a background in mathematics and AI, focuses on understanding patient populations and improving clinical trials. He explains how NetraMark’s AI technology can analyze small, complex data sets to identify treatment and placebo responder subpopulations and improve drug efficacy. Dr. Geraci emphasizes the potential of adaptive trials and the importance of personalized medicine. He predicts the future of AI in clinical trials will involve modular AI systems integrating pattern-finding and language interfaces to enhance drug development and patient care.

Full episode:

Other ways to listen:

 

 

 

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.